John L. Zabriskie
Nessuna posizione attualmente
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Robert Conway | M | 70 | 25 anni | |
| Gary Pilnick | M | 58 | 24 anni | |
| Thomas Keuer | M | 65 | 18 anni | |
| Amit Banati | M | 55 | 12 anni | |
| Melvin A. Snyder | M | 81 |
MacroChem Corp.
 MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 24 anni |
| Kurt Forche | M | 54 | 27 anni | |
| Sharon Perry | F | - | 16 anni | |
| John Min | M | - | 14 anni | |
| Linda Grais | M | 68 | 17 anni | |
| Patricia Russo | F | 71 | 29 anni | |
| Mary Laschinger | F | 64 | 12 anni | |
| Donald Knauss | M | 73 | 17 anni | |
| John Renwick | M | - | 24 anni | |
| Nicolas Amaya | M | - | 23 anni | |
| Rodrigo Lance | M | - | 27 anni | |
| Kris Bahmer | F | - | 18 anni | |
| Kris Charles | F | - | 18 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John Bryant | M | 58 | 20 anni | |
| Arnold G. Langbo | M | 86 | 44 anni | |
| Allan Mackay | M | 68 | 11 anni | |
| Kenneth Frazier | M | 69 | 30 anni | |
| Carlos Gutierrez | M | 70 | 30 anni | |
| P. Vagelos | M | 94 | 19 anni | |
| Kevin Koch | M | 63 | 15 anni | |
| Richard B. Brewer | M | 72 |
ARCA biopharma, Inc. /Old/
 ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 6 anni |
| Janet Carrig | F | 66 | 4 anni | |
| Michael Bristow | M | 79 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 5 anni |
| Francis J. Bullock | M | 87 | 14 anni | |
| James Jenness | M | 77 | 21 anni | |
| Burton E. Sobel | M | 86 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 9 anni |
| Christopher Ozeroff | M | 65 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 5 anni |
| Patrick M. Wheeler | M | 54 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 8 anni |
| Raymond Gilmartin | M | 82 | 2 anni | |
| Robert de Luccia | M | 78 |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 5 anni |
| Alvin J. Karloff | M | - |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 11 anni |
| Annunciata Cerioli | F | 62 | 7 anni | |
| Robert Palmisano | M | 79 |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 2 anni |
| Bernard R. Patriacca | M | 79 |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 7 anni |
| Joseph Romanelli | M | 50 | 19 anni | |
| Richard P. Bourgerie | M | - |
Dartmouth College
| 5 anni |
| Angela Geffre | M | - | 6 anni | |
| J. William Freytag | M | 72 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 4 anni |
| Marino Carol | F | - | 8 anni | |
| Ulf Rosén | M | 64 |
Pharmacia & Upjohn, Inc.
| 3 anni |
| Derek K. Cole | M | - | 3 anni | |
| David G. Lowe | M | 67 |
ARCA biopharma, Inc. /Old/
ARCA biopharma, Inc. /Old/ Pharmaceuticals: MajorHealth Technology ARCA biopharma, Inc. develops genetic therapies for heart failure and cardiovascular diseases. It offers Gencaro product, is an investigational pharmacologically unique beta-blocker and mild vasodilator being developed for heart failure and other indications. The company was founded by Michael R. Bristow and is headquartered in Denver, CO. | 2 anni |
| Sterling K. Speirn | M | 76 | 7 anni | |
| John Robinson | M | 50 | - | |
| Raymond Woosley | M | 81 | 11 anni | |
| Brian L. Selby | M | 62 | 14 anni | |
| Pekka Tennilä | M | 55 | 3 anni | |
| John Orwin | M | 59 | 7 anni | |
| Ron Squarer | M | 57 | 7 anni | |
| Robert Steele | M | 67 | 5 anni | |
| Andrew Robbins | M | 48 | 7 anni | |
| David Gionco | M | 63 | 3 anni | |
| Joel R. Wittenberg | M | - | - | |
| Gwen A. Fyfe | M | 72 | 7 anni | |
| Liam Ratcliffe | M | 60 | 2 anni | |
| David Luci | M | 57 |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 2 anni |
| Rogelio M. Rebolledo | M | 79 | 9 anni | |
| Jean-Francois Formela | M | 67 | 7 anni | |
| Donald S. Brooks | M | 88 | - | |
| Alan Harris | M | 70 | 23 anni | |
| Dorothy A. Johnson | F | 83 | 15 anni | |
| Fred Hassan | M | 78 |
Pharmacia & Upjohn, Inc.
| 3 anni |
| John T. Dillon | M | 85 | 18 anni | |
| Cynthia Hardin Milligan | F | 77 | - | |
| Maribeth A. Dangel | F | 58 | 18 anni | |
| John Moore | M | 59 | 15 anni | |
| Kathryn Falberg | F | 63 | - | |
| Gil van Lunsen | M | 81 | 17 anni | |
| Anthony D. Piscopio | M | - | 8 anni | |
| Glenn Edward Deegan | M | 57 |
MacroChem Corp.
MacroChem Corp. Pharmaceuticals: MajorHealth Technology MacroChem Corp. Develops pharmaceutical products to prevent chemicals in insect repellant from penetrating the skin. Its drug delivery technologies include Soft Enhancement of Percutaneous Absorption, MacroDem and DermaPass. The company was founded in 1982 and is located in Wellesley Hills, MI. | 6 anni |
| H. Nicholas Muller | M | 84 |
Rochester Christian University
Dartmouth College
| 8 anni |
| Mary K. Pendergast | F | 73 | - | |
| Richard Markham | M | 73 | 20 anni | |
| Benjamin Carson | M | 73 | 18 anni | |
| Kyu-Sung Lee | M | 64 | 10 anni | |
| Clark Golestani | M | 57 | 24 anni | |
| Wendy Dixon | M | 68 | 5 anni | |
| Wei Tang | M | - | 15 anni | |
| Sarah S. Toomey | F | 50 | 3 anni | |
| Michel Vounatsos | M | 62 | 20 anni | |
| Ron Newbold | M | - | 13 anni | |
| Eric W. Kimble | M | 58 | 5 anni | |
| Egil Bodd | M | 69 | 11 anni | |
| Nolan Sigal | M | 73 | 10 anni | |
| Carole A. Sable | M | 62 | 12 anni | |
| Charles Popper | M | - | 7 anni | |
| William L. Delaat | M | 72 | 11 anni | |
| William G. Roberts | M | 66 | 6 anni | |
| Johnnetta Betsch Cole | M | 87 | 15 anni | |
| Abraham E. Cohen | M | 87 | 10 anni | |
| Michael Tarnow | M | 79 | 22 anni | |
| C. Boyd Clarke | M | 74 | 19 anni | |
| R. Gordon Douglas | M | 89 | 8 anni | |
| Robert G. Johnson | M | 72 | 7 anni | |
| Jeffrey A. Peris | M | 77 | 25 anni | |
| John Kapp | M | - | 13 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- John L. Zabriskie
- Contatti personali
